Florida Cancer ReTOOL Program for Underrepresented Minority Students

摘要 少数民族在基础、临床和行为研究中的代表性不足被视为一个重大问题， 解决癌症差异的障碍，以及将少数群体纳入临床试验。因此， 需要培养一支种族和族裔多样、训练有素的科学家骨干队伍。在这个应用程序中，我们将 解决代表性不足的少数群体面临的下列障碍， 创新的方法，将创造机会，促进癌症研究的职业生涯，为代表性不足 少数群体研究人员和学生：㈠缺乏坚定的榜样，㈡指导不足，㈢ 准备不足，（iv）期望值低，（v）不了解科学文化和习惯用语。到 实现我们的长期目标，增加代表性不足的少数民族（URM）癌症研究人员的库，我们的 主要目标是加强，促进和维持一个独立的，有竞争力的癌症研究培训 该计划通过为少数民族学生创造机会并促进肿瘤学职业发展， 杰出领导者综合研究培训机会（C-ReTOOL）计划。这个程序 将通知和文化敏感的本科生和研究生的需要，以减少 通过基础、临床和行为研究，少数群体的癌症负担不成比例 在美国、欧洲、非洲和加勒比地区进行。C-ReTOOL计划将建立在我们现有的癌症 研究和培训机会，以增加代表性不足的科学家和临床研究人员的数量 在高等教育和学术领导方面。

ABSTRACT The underrepresentation of minorities in basic, clinical and behavioral research has been viewed as a significant barrier to addressing cancer disparities, and the inclusion of minority populations in clinical trials. Thus, there is a need to develop a cadre of racially and ethnically diverse, well-trained scientists. In this application, we will address the following barriers that underrepresented minorities face for a comprehensive rigorous, and innovative approach that will create opportunities and promote careers in cancer research for underrepresented minority researchers and students: (i) the lack of committed role models, (ii) inadequate mentoring, (iii) insufficient preparation, (iv) low expectations, and (v) not being aware of the culture and idioms of science. To achieve our long-term goal of increasing the pool of underrepresented minority (URM) cancer researchers, our primary objective is to augment, promote and sustain an independent, competitive cancer research training program that creates opportunities and promotes careers in oncology for minority students through the Comprehensive Research Training Opportunities for Outstanding Leaders (C-ReTOOL) program. This program will apprise and culturally sensitize undergraduate and graduate students of the need to reduce the disproportionate cancer burden in minority populations through basic, clinical, and behavioral research conducted in the US, Europe, Africa and the Caribbean. The C-ReTOOL program will build on our existing cancer research and training opportunities to grow the number of underrepresented scientists and clinical investigators in higher education and academic leadership.